Physician

Ghassan S Safadi, M.D.

According to 2025 Medicare claims, Ghassan Safadi, M.D. (NPI: 1003813205) practices allergy/immunology in the Toledo, OH market, with the plurality of this provider's patient population coming from Lucas, OH. This provider's primary affiliated billing organization is DR. SAFADI & ASSOCIATES, INC (NPI: 1861520173; TIN: 300170577) and primary practice location at 43617-1514.

Safadi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 422 traditional Medicare patients, billed 59,371 HCPCS/CPT codes, and received $975,975 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,203 prescription claims across 513 beneficiaries totaling $1,356,131 in drug costs, led by Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50). DME data shows 396 claims. Open Payments data shows 57 records totaling $1,132. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $312,487 to $975,975. Similarly, Part D prescription costs have risen steadily, from $82,349 to $1,356,131. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,632 to $8,698.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	312	29,264	$312,487
2016	464	36,244	$347,301
2017	409	35,013	$499,917
2018	356	36,710	$703,275
2019	292	29,948	$710,461
2020	280	25,291	$590,341
2021	225	24,040	$580,048
2022	358	29,695	$654,489
2023	437	48,000	$853,561
2024	422	59,371	$975,975

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	228	1,022	$82,349
2016	299	1,520	$288,951
2017	324	1,832	$271,808
2018	318	1,753	$199,446
2019	282	1,591	$187,150
2020	305	1,614	$252,786
2021	303	1,568	$180,133
2022	410	1,659	$210,283
2023	495	2,936	$763,935
2024	513	3,203	$1,356,131

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	79	$146,137
2021	N/R	90	$168,644
2022	N/R	117	$196,463
2023	11	358	$439,052
2024	N/R	396	$953,397

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	162	210	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	137	182	$61
95165	Professional service for preparation and provision of 1 or more antigens	155	8,639	$10
95117	Professional service for multiple injections of allergen	163	3,318	$8
95004	Test for allergy using allergenic extract	129	8,830	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	38	1,064	$280,285
Hyqvia	Igg/Hyaluronidase,recombinant	30	840	$247,609
Cuvitru	Immun Glob G(Igg)/Gly/Iga Ov50	13	364	$115,070
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	12	336	$109,093
Dupixent Pen	Dupilumab	22	616	$80,921

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1554	Injection, immune globulin (asceniv), 500 mg	N	N/R	26	$400,672
J1575	Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin	N	N/R	50	$241,021
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	31	$174,225
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	18	$51,581
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	12	$40,938

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	57	$1,132	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ghassan S. Safadi, M.D.?

Tedicare shows public-source Medicare data for Ghassan S. Safadi, M.D. (NPI 1003813205), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ghassan S. Safadi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ghassan S. Safadi, M.D.?

Ghassan S. Safadi, M.D. is linked to DR. SAFADI & ASSOCIATES, INC (billing NPI 1861520173) in the available physician profile data.

Does Ghassan S. Safadi, M.D. have Open Payments data?

Ghassan S. Safadi, M.D. has 57 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.